UPC Analytics
ENDE
Overview · Filed: Dec 8, 2025

UPC_CoA_917/2025

Methods of Using Sustained Release Aminopyridine Compositions

AppealsMain AppealCourt of AppealAppealOral Phase
OverviewDecisionsDocumentsTimeline
Parties

Claimants

  • Merz Pharmaceuticals LLC
  • Merz Therapeutics GmbH
  • Merz Pharma France

Respondents

  • Viatris Santé
Judges
  • Rian Kalden
  • Ingeborg Simonsson
  • Patricia Rombach
  • Anna Hedberg
  • Jeroen Meewisse
Patents
  • EP2377536
CPC codes: A61P43/00, A61P19/08, A61K31/435, A61P25/28, A61K9/20, A61K31/44, A61P21/00, A61P17/02, A61K31/4409, A61P25/00

Sector: Pharmaceutical & Medical

Outcome
Procedural only
Filed: Dec 8, 2025
First decided: Jan 26, 2026
Language: English
Open on UPC Registry